Rapid infectious disease test Xpert®

for bacteriaC. difficilelaboratory

C. difficile infections (CDI) have been increasing in incidence and severity, and are associated with an increase in length of hospital stay, costs, morbidity and mortality.2 Highly virulent (027-NAP1-BI) strains have caused outbreaks of severe disease in Europe and North America3 Binary toxin (BT) may be important because of: Links to both disease severity and outcome4 Strains such as 033 are positive only for binary toxin and not toxins A and B, yet have caused CDI5,6 The Solution CDI has become a substantive and growing burden in hospitalised patients prompting the need for earlier and accurate detection. Xpert® C. difficile BT enables: Broad coverage with multiple targets, including: toxin B (tcdB), binary toxin (cdtA), and the tcdC deletion at base 117 associated with the ribotype 027 strain, a predictor of severe CDI and mortality8 Optimised and prompt administering of therapy to support improved patient outcomes9 Timely infection control initiatives to reduce the spread of infection10 Laboratory efficiencies with on-demand workflows requiring minimal hands-on time and no repeat testing1,11 The Impact On-demand answers, anywhere and anytime your patients need care